0001401914-20-000079.txt : 20200707 0001401914-20-000079.hdr.sgml : 20200707 20200604142946 ACCESSION NUMBER: 0001401914-20-000079 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-926-7655 MAIL ADDRESS: STREET 1: 3655 NOBEL DRIVE STREET 2: SUITE 260 CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 CORRESP 1 filename1.htm Document


June 4, 2020

Via EDGAR
Division of Corporation Finance
Office of Life Sciences
Attn: Laura Crotty
U.S. Securities and Exchange Commission 100 F Street, NE
Washington, DC 20549
 
Re:
Daré Bioscience, Inc.
Registration Statement on Form S-3
Filed May 15, 2020
File No. 333-238299
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, Daré Bioscience, Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced registration statement to 9:00 a.m., Eastern Time, on Monday, June 8, 2020, or as soon thereafter as practicable.
 
Daré Bioscience, Inc.

 
 
 
/s/ Lisa Walters-Hoffert
 
Lisa Walters-Hoffert
 
Chief Financial Officer